Recent Thymic Emigrants and Tregs Expressing CD31 and CD45RA Are Decreased at Day 100 and Prognostic for Chronic GvHD in Children: Results From the Applied Biomarkers of Late Effects (ABLE)/Pediatric Blood and Marrow Transplant Consortium 1202 Study

Geoff D.E. Cuvelier(CancerCare Manitoba), Kirk R. Schultz(University of British Columbia), Michael A. Pulsipher(Primary Children's Hospital), Alexandra Cheerva(Kosair Children's Hospital), Süreyya Savaşan(Children's Hospital of Michigan), Andrew C. Harris(Primary Children's Hospital), Emi Caywood(Alfred I. duPont Hospital for Children), Michael Joyce, Monica Bhatia(Columbia University Irving Medical Center), Eneida R. Nemecek(Oregon Health & Science University), Anat Halevy(University of British Columbia), Tal Schechter(Hospital for Sick Children), Benjamin Oshrine(Johns Hopkins All Children's Hospital), Justin T. Wahlstrom(University of California, San Francisco), Victor Lewis(Alberta Children's Hospital), Sung Won Choi(University of Michigan), K.A. Kasow(University of North Carolina at Chapel Hill), Amina Kariminia(University of Washington), Carrie L. Kitko(Vanderbilt University Medical Center), David A. Jacobsohn(Children's National), Sonali Chaudhury(Northwestern University), Anna Pawłowska(City of Hope), Joseph H. Chewning(Kettering University), David Mitchell(Montreal Children's Hospital), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Albert Kheradpour(Loma Linda University Medical Center), Gail Megason(University of Mississippi Medical Center), Allyson Flower(New York Medical College), Donald W. Coulter(University of Nebraska Medical Center)
Transplantation and Cellular Therapy
February 3, 2018
Cited by 0


Related Papers